vimarsana.com

Page 3 - சர்வதேச இதழ் ஆஃப் பெண்கள் தோல் நோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Another COVID-19 Side Effect: Zoom Dysmorphia

email article As the COVID-19 pandemic swept across the U.S., millions of people turned to video conferencing for work and social interaction and many of them didn t like what they saw. Most people go through life with an outward-facing perspective. During professional, social, or personal interactions, they look at other people, not themselves. The transition to remote working and interpersonal communication forced many people to spend more time sometimes hours a day looking at themselves on digital screens. For some, the experience has led to skewed perceptions of their appearance severely skewed in some cases.

PureTech Announces Annual Results for Year Ended December 31, 2020

PureTech Announces Annual Results for Year Ended December 31, 2020 By Staff 2 seconds ago Strong capital base and cash runway extended into the first quarter of 2025, with PureTech level cash and cash equivalents of $443.4 million as of March 31, 2021 1 ($349.4 million as of December 31, 2020 2) and consolidated cash and cash equivalents of $486.5 million as of March 31, 2021 3 ($403.9 million as of December 31, 2020 4) Advancement of Wholly Owned Pipeline with four clinical trial initiations and one successful readout, with three clinical trials ongoing Significant milestones across PureTech’s Founded Entities including one FDA Clearance for Marketing, two European Marketing Authorizations, initiation of a Phase 3 program, $247.8 million raised in 2020 5 and $473.2 million raised in the 2021 post-period

Has the Work-From-Home Era Led to a Plastic Surgery Boom?

Is Zoom Dysmorphia Giving Rise to a Plastic Surgery Boom? Michael Stahl, provided by FacebookTwitterEmail For years, Marie, a pseudonymous woman living in the Bay Area, subjected herself to extraordinary levels of vulnerability: She taught English to high school freshmen. “Fourteen-year-olds are some of the most judgemental people on the planet,” Marie says. “I stood in front of them for hours every day and I did not feel the level of self consciousness that I started to feel when I had to be on Zoom all the time.” The 27-year-old is between careers now, working toward a project management graduate degree. Still, if she wanted to continue her studies this past pandemic year, like so many more students, professionals, or anyone else seeking connectivity with others, Marie was forced to fire up video-conference calls.

PureTech Founded Entity Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Womens Dermatology

An MGH pilot study evaluating scalp skin disruption using Follica’s proprietary Hair Follicle Neogenesis stimulation product was published in International Journal of Women’s Dermatology, demonstrating the treatment promoted hair growth in female pattern hair loss. The study endpoints included photographs, patient-reported improvement and physician-documented Sinclair score. The pilot study, led by Maryanne M. Senna, M.D., an assistant professor of dermatology at Harvard Medical School, enrolled 11 women with mild to moderate FPHL who had been on stable existing treatments for six or more months. Patients underwent six treatments with the Follica proprietary Hair Follicle Neogenesis (HFN) device and application of a topical on-market drug on non-treatment days. The scalp treatments with the HFN device, which last just a few minutes, stimulate stem cells and enable the growth of new hair follicles. A topical drug is then applied to enhance efficacy by thickening new hair follicle

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.